Navigation Links
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Date:4/28/2009

Long-term Data Presented at AUA Annual Meeting

CHICAGO, April 28 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today released new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone undecanoate (NEBIDO(R) -- 750 mg) injection, a long-acting testosterone replacement therapy in development in the U.S. for treatment of hypogonadism. Results showed that average testosterone levels were maintained within the normal range over the 21-month study, and NEBIDO was generally well tolerated. The long-term clinical trial data were presented at the annual meeting of the American Urological Association.

Previously reported Phase III data evaluated NEBIDO's effectiveness and safety over the initial six-month treatment period in these hypogonadal men, with 94 percent of patients achieving an average testosterone level within the normal range (300-1000 ng/dL) over the 10-week treatment interval. At initiation of treatment, the average testosterone level for the patients rose into the normal range at the first sampling point, four days following the first injection. The new long-term data showed that average testosterone levels remained in the normal range throughout the 21-month study, and that NEBIDO was generally well tolerated. NEBIDO is currently under review at the U.S. Food and Drug Administration.

"Symptoms of low testosterone can be non-specific and may be dismissed as the natural consequence of aging," said Dr. Abraham Morgentaler, a leading investigator of the study and Director of Men's Health Boston, and Associate Clinical Professor of Urology at Harvard Medical School. "But treating hypogonadism can result in significant health benefits for patients."

STUDY RESULTS

This open-la
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Male Hormone Replacement Company Renewman.com Critical of MLB for Testosterone Abuse Publicity
2. Womens Testosterone Patch May Not Work
3. Prostate cancer drug reduces testosterone levels in as little as 3 days
4. Study shows testosterone improves sexual well-being in post-menopausal women
5. Testosterone Patch Restores Libido in Postmenopausal Women
6. Testosterone key to disease transmission
7. AUDIO from Medialink and Solvay: Men Suffering From Symptoms of Low Testosterone Should Talk to Their Doctor
8. Studies Support Testosterone Supplements for Older Men
9. Gamma Labs to Boost Testosterone At World Series of Poker In Las Vegas
10. Men With Low Testosterone Not Receiving Treatment
11. Many men with low testosterone levels do not receive treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 i2i Systems Population ... by Chase Brexton Health Care, a 35-year-old Maryland-based ... Chase Brexton provides comprehensive primary care, behavioral health ... across seven clinics in the greater Baltimore area ... medical records, the organization has always focused on ...
(Date:3/4/2015)... 2015 Dietary supplement company MitoSynergy ... first biocompatible copper chelate, at Natural Products Expo West ... chance to gain insight into their wellness through a ... complex can support their individual nutritional needs, all while ... the core ingredient of the MitoSynergy product line, was ...
(Date:3/4/2015)... Dallas, TX (PRWEB) March 04, 2015 ... comprehensive information on the therapeutic development for Vasculitis. Vasculitis ... vessels. The actual cause of vasculitis diseases is not ... have a wide range of symptoms. Symptoms can include ... and loss of a pulse in a limb. Vasculitis ...
(Date:3/4/2015)... TheraBreath is proud to announce a new probiotic lozenge ... with overall health. , Many health experts agree that ... bad bacteria that can cause unwanted infections. While most people ... will need the help of a probiotic to elevate the ... Packed with the S. salivarius M18 & K12 strains of ...
(Date:3/4/2015)... 2015 Theme and plugin developers from ... for Final Cut Pro X entitled ProFont NoteBook , “ProFont ... any FCPX editors project.” Said Christiana Austin, CEO of Pixel ... add animated font to their FCPX media.” , With ProFont ... within Final Cut Pro X. ProFont Notebook offers users up ...
Breaking Medicine News(10 mins):Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2
... where endometrial tissue, which is normally found only in ... // and attaches itself to ligaments and organs in ... include pain, bleeding, inflammation, adhesions and infertility. ... with endometriosis are at higher risk of having migraines. ...
... be a strong link between Skin Allergies and cancer. People who ... blood related caners as they grow older. A Swedish team of ... of the BMC public Health. ,In this alarming finding ... likely to develop Leukemia and those of us who have ...
... studying around 700,000 people researchers say dads who have ... risk // for developing schizophrenia later in life. ... admitted to the hospital in Sweden between 1989 and ... psychosis. Researchers say they found a strong association between ...
... samples for viral RNA among organ and tissue donors who ... // transmission among transplant recipients, say researchers according to a ... diseases such as HIV or hepatitis C is the usual ... may be infected with a virus but show a full ...
... suffer from sleep apnea run a higher risk of complications ... apnea is a condition in which patients stop breathing periodically ... the condition, known as obstructive sleep apnea, affects as many ... of all middle-aged women. ,Researchers say 80 percent of ...
... to gain complete control of their condition, say researchers ... uncontrolled asthma. Some of the patients had never before ... on a low-dose inhaled steroid; and some were on ... were randomly assigned to receive either the inhaled steroid ...
Cached Medicine News:
(Date:3/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming 27 th Annual ROTH Conference, taking place ...  Dr. Michael Berelowitz , Chairman of ... corporate overview on March 10, 2015.   ...
(Date:3/4/2015)... March 4, 2015 Perrigo Company plc (NYSE: ... and CEO Joseph C. Papa will present at ... Wednesday, March 11, 2015 at the Loews Miami Beach Hotel ... access the presentation webcast at http://perrigo.investorroom.com/events-webcasts . ... in 1887, Perrigo Company plc, headquartered in Ireland ...
(Date:3/3/2015)... , March 3, 2015  The packaging industry ... It not only provides containment and drug safety ... proper delivery. As patent loss delivers more generics ... steadily rise, in turn encouraging low-cost innovation in ... expected to drive the pharmaceutical packaging industry towards ...
Breaking Medicine Technology:Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4
... BOONTON, N.J., Jan. 4, 2012   Unigene Laboratories, Inc. ... design, delivery, manufacture and development of peptide-based therapeutics, announced ... present a corporate overview at the Biotech Showcase™ 2012 ... at 11:30 a.m. PT (2:30 p.m. ET).  Mr. Palmer,s presentation ...
... 4, 2012  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced ... J.P. Morgan Healthcare Conference to be held January 9-12, ... Francisco, CA.  Mr. Adrian Adams, Chief Executive Officer and ... Company and its product pipeline at 2:00 p.m. PT ...
Cached Medicine Technology:Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9 2Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 3Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference 4
Test for determination of rheumatoid factor....
... The SYNCHRON CX4 Delta Specialty / ... access analyzer that can consolidate Drugs ... testing, such as thyroid, HbA1c and ... CX4 Delta offers a level of ...
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
Medicine Products: